EP 1003859 A1 20000531 - USE OF TRANSCRIPTION FACTOR BRN-3A
Title (en)
USE OF TRANSCRIPTION FACTOR BRN-3A
Title (de)
VERWENDUNG VON TRANSKRIPTIONSFAKTOR BRN-3A
Title (fr)
UTILISATION DU FACTEUR DE TRANSCRIPTION BRN-3A
Publication
Application
Priority
- GB 9802228 W 19980727
- GB 9715823 A 19970725
- US 98847697 A 19971210
Abstract (en)
[origin: WO9905272A1] The present invention provides a polypeptide comprising transcription factor Brn-3a or a derivative thereof for use in a method of treatment of the human or animal body by therapy.
IPC 1-7
C12N 15/12; C12N 15/86; C07K 14/47; C12N 7/00; A61K 48/00; A61K 39/245; A61K 38/17
IPC 8 full level
A61K 38/17 (2006.01); A61K 39/245 (2006.01); A61K 48/00 (2006.01); A61P 25/00 (2006.01); C07K 14/47 (2006.01); C12N 7/00 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 25/00 (2017.12); C07K 14/4705 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01); C12N 2799/028 (2013.01)
Citation (search report)
See references of WO 9905272A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9905272 A1 19990204; WO 9905272 A9 19991028; AU 8548198 A 19990216; CA 2298107 A1 19990204; EP 1003859 A1 20000531; IL 134210 A0 20010430; JP 2001511344 A 20010814
DOCDB simple family (application)
GB 9802228 W 19980727; AU 8548198 A 19980727; CA 2298107 A 19980727; EP 98936506 A 19980727; IL 13421098 A 19980727; JP 2000504246 A 19980727